Rare Neurological Disease Treatment Market - Global Outlook and Forecast 2022-2028

March 2022 | 67 pages | ID: RFACC0B691FEEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Rare Neurological Disease Treatment in Global, including the following market information:

Global Rare Neurological Disease Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Rare Neurological Disease Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Biologics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Rare Neurological Disease Treatment include Pfizer, Allergan, Novartis, Bayer Aktiengesellschaft, Medtronic, Sanofi, Johnson & Johnson and Teva Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rare Neurological Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Rare Neurological Disease Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Rare Neurological Disease Treatment Market Segment Percentages, by Type, 2021 (%)

• Biologics
• Organic Compounds

Global Rare Neurological Disease Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Rare Neurological Disease Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Rare Neurological Disease Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Rare Neurological Disease Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Rare Neurological Disease Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Rare Neurological Disease Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Allergan
• Novartis
• Bayer Aktiengesellschaft
• Medtronic
• Sanofi
• Johnson & Johnson
• Teva Pharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Rare Neurological Disease Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Rare Neurological Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RARE NEUROLOGICAL DISEASE TREATMENT OVERALL MARKET SIZE

2.1 Global Rare Neurological Disease Treatment Market Size: 2021 VS 2028
2.2 Global Rare Neurological Disease Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Rare Neurological Disease Treatment Players in Global Market
3.2 Top Global Rare Neurological Disease Treatment Companies Ranked by Revenue
3.3 Global Rare Neurological Disease Treatment Revenue by Companies
3.4 Top 3 and Top 5 Rare Neurological Disease Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Rare Neurological Disease Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Rare Neurological Disease Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Rare Neurological Disease Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Rare Neurological Disease Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Rare Neurological Disease Treatment Market Size Markets, 2021 & 2028
  4.1.2 Biologics
  4.1.3 Organic Compounds
4.2 By Type - Global Rare Neurological Disease Treatment Revenue & Forecasts
  4.2.1 By Type - Global Rare Neurological Disease Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Rare Neurological Disease Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Rare Neurological Disease Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Rare Neurological Disease Treatment Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Rare Neurological Disease Treatment Revenue & Forecasts
  5.2.1 By Application - Global Rare Neurological Disease Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Rare Neurological Disease Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Rare Neurological Disease Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Rare Neurological Disease Treatment Market Size, 2021 & 2028
6.2 By Region - Global Rare Neurological Disease Treatment Revenue & Forecasts
  6.2.1 By Region - Global Rare Neurological Disease Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Rare Neurological Disease Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Rare Neurological Disease Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Rare Neurological Disease Treatment Revenue, 2017-2028
  6.3.2 US Rare Neurological Disease Treatment Market Size, 2017-2028
  6.3.3 Canada Rare Neurological Disease Treatment Market Size, 2017-2028
  6.3.4 Mexico Rare Neurological Disease Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Rare Neurological Disease Treatment Revenue, 2017-2028
  6.4.2 Germany Rare Neurological Disease Treatment Market Size, 2017-2028
  6.4.3 France Rare Neurological Disease Treatment Market Size, 2017-2028
  6.4.4 U.K. Rare Neurological Disease Treatment Market Size, 2017-2028
  6.4.5 Italy Rare Neurological Disease Treatment Market Size, 2017-2028
  6.4.6 Russia Rare Neurological Disease Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Rare Neurological Disease Treatment Market Size, 2017-2028
  6.4.8 Benelux Rare Neurological Disease Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Rare Neurological Disease Treatment Revenue, 2017-2028
  6.5.2 China Rare Neurological Disease Treatment Market Size, 2017-2028
  6.5.3 Japan Rare Neurological Disease Treatment Market Size, 2017-2028
  6.5.4 South Korea Rare Neurological Disease Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Rare Neurological Disease Treatment Market Size, 2017-2028
  6.5.6 India Rare Neurological Disease Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Rare Neurological Disease Treatment Revenue, 2017-2028
  6.6.2 Brazil Rare Neurological Disease Treatment Market Size, 2017-2028
  6.6.3 Argentina Rare Neurological Disease Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Rare Neurological Disease Treatment Revenue, 2017-2028
  6.7.2 Turkey Rare Neurological Disease Treatment Market Size, 2017-2028
  6.7.3 Israel Rare Neurological Disease Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Rare Neurological Disease Treatment Market Size, 2017-2028
  6.7.5 UAE Rare Neurological Disease Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Rare Neurological Disease Treatment Major Product Offerings
  7.1.4 Pfizer Rare Neurological Disease Treatment Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Allergan
  7.2.1 Allergan Corporate Summary
  7.2.2 Allergan Business Overview
  7.2.3 Allergan Rare Neurological Disease Treatment Major Product Offerings
  7.2.4 Allergan Rare Neurological Disease Treatment Revenue in Global Market (2017-2022)
  7.2.5 Allergan Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Rare Neurological Disease Treatment Major Product Offerings
  7.3.4 Novartis Rare Neurological Disease Treatment Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 Bayer Aktiengesellschaft
  7.4.1 Bayer Aktiengesellschaft Corporate Summary
  7.4.2 Bayer Aktiengesellschaft Business Overview
  7.4.3 Bayer Aktiengesellschaft Rare Neurological Disease Treatment Major Product Offerings
  7.4.4 Bayer Aktiengesellschaft Rare Neurological Disease Treatment Revenue in Global Market (2017-2022)
  7.4.5 Bayer Aktiengesellschaft Key News
7.5 Medtronic
  7.5.1 Medtronic Corporate Summary
  7.5.2 Medtronic Business Overview
  7.5.3 Medtronic Rare Neurological Disease Treatment Major Product Offerings
  7.5.4 Medtronic Rare Neurological Disease Treatment Revenue in Global Market (2017-2022)
  7.5.5 Medtronic Key News
7.6 Sanofi
  7.6.1 Sanofi Corporate Summary
  7.6.2 Sanofi Business Overview
  7.6.3 Sanofi Rare Neurological Disease Treatment Major Product Offerings
  7.6.4 Sanofi Rare Neurological Disease Treatment Revenue in Global Market (2017-2022)
  7.6.5 Sanofi Key News
7.7 Johnson & Johnson
  7.7.1 Johnson & Johnson Corporate Summary
  7.7.2 Johnson & Johnson Business Overview
  7.7.3 Johnson & Johnson Rare Neurological Disease Treatment Major Product Offerings
  7.7.4 Johnson & Johnson Rare Neurological Disease Treatment Revenue in Global Market (2017-2022)
  7.7.5 Johnson & Johnson Key News
7.8 Teva Pharmaceutical
  7.8.1 Teva Pharmaceutical Corporate Summary
  7.8.2 Teva Pharmaceutical Business Overview
  7.8.3 Teva Pharmaceutical Rare Neurological Disease Treatment Major Product Offerings
  7.8.4 Teva Pharmaceutical Rare Neurological Disease Treatment Revenue in Global Market (2017-2022)
  7.8.5 Teva Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Rare Neurological Disease Treatment Market Opportunities & Trends in Global Market
Table 2. Rare Neurological Disease Treatment Market Drivers in Global Market
Table 3. Rare Neurological Disease Treatment Market Restraints in Global Market
Table 4. Key Players of Rare Neurological Disease Treatment in Global Market
Table 5. Top Rare Neurological Disease Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Rare Neurological Disease Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Rare Neurological Disease Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Rare Neurological Disease Treatment Product Type
Table 9. List of Global Tier 1 Rare Neurological Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rare Neurological Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Rare Neurological Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Rare Neurological Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Rare Neurological Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Rare Neurological Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Rare Neurological Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Rare Neurological Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Rare Neurological Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Rare Neurological Disease Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Rare Neurological Disease Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Rare Neurological Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Rare Neurological Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Rare Neurological Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Rare Neurological Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Rare Neurological Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Rare Neurological Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Rare Neurological Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Rare Neurological Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Rare Neurological Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Rare Neurological Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Rare Neurological Disease Treatment Product Offerings
Table 32. Pfizer Rare Neurological Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Allergan Corporate Summary
Table 34. Allergan Rare Neurological Disease Treatment Product Offerings
Table 35. Allergan Rare Neurological Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Rare Neurological Disease Treatment Product Offerings
Table 38. Novartis Rare Neurological Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Bayer Aktiengesellschaft Corporate Summary
Table 40. Bayer Aktiengesellschaft Rare Neurological Disease Treatment Product Offerings
Table 41. Bayer Aktiengesellschaft Rare Neurological Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Medtronic Corporate Summary
Table 43. Medtronic Rare Neurological Disease Treatment Product Offerings
Table 44. Medtronic Rare Neurological Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Sanofi Corporate Summary
Table 46. Sanofi Rare Neurological Disease Treatment Product Offerings
Table 47. Sanofi Rare Neurological Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Johnson & Johnson Corporate Summary
Table 49. Johnson & Johnson Rare Neurological Disease Treatment Product Offerings
Table 50. Johnson & Johnson Rare Neurological Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Teva Pharmaceutical Corporate Summary
Table 52. Teva Pharmaceutical Rare Neurological Disease Treatment Product Offerings
Table 53. Teva Pharmaceutical Rare Neurological Disease Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Rare Neurological Disease Treatment Segment by Type in 2021
Figure 2. Rare Neurological Disease Treatment Segment by Application in 2021
Figure 3. Global Rare Neurological Disease Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Rare Neurological Disease Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Rare Neurological Disease Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Rare Neurological Disease Treatment Revenue in 2021
Figure 8. By Type - Global Rare Neurological Disease Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Rare Neurological Disease Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Rare Neurological Disease Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Rare Neurological Disease Treatment Revenue Market Share, 2017-2028
Figure 12. US Rare Neurological Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Rare Neurological Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Rare Neurological Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Rare Neurological Disease Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Rare Neurological Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Rare Neurological Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Rare Neurological Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Rare Neurological Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Rare Neurological Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Rare Neurological Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Rare Neurological Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Rare Neurological Disease Treatment Revenue Market Share, 2017-2028
Figure 24. China Rare Neurological Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Rare Neurological Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Rare Neurological Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Rare Neurological Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Rare Neurological Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Rare Neurological Disease Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Rare Neurological Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Rare Neurological Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Rare Neurological Disease Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Rare Neurological Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Rare Neurological Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Rare Neurological Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Rare Neurological Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Rare Neurological Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Allergan Rare Neurological Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Rare Neurological Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bayer Aktiengesellschaft Rare Neurological Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Medtronic Rare Neurological Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sanofi Rare Neurological Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Johnson & Johnson Rare Neurological Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Teva Pharmaceutical Rare Neurological Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)